Health AI is becoming a category.
Most of it is not ready.
AI is already informing clinical and consumer health decisions.
Validation ends at deployment — failure does not announce itself.
A term everyone chose.
A standard nobody set.
Health AI refers to artificial intelligence systems designed to answer health questions, support clinical decisions, or manage health-related tasks for consumers, patients, or healthcare providers. It is a category — not a single product — encompassing clinical diagnostics, consumer safety tools, and AI systems operating at the scale of cities and health systems.
In 2025 and 2026, Amazon, Microsoft, Google, Apple, OpenAI, and Anthropic each independently launched or announced health-focused AI products — and each chose the same descriptor: Health AI. That convergence is not coincidence. It is the market naming a category that is forming in real time.
The category is forming now. The standards have not been set. The work of defining what validated health AI actually requires — evidence tiers, governance structure, consistent outputs, auditability — has been underway at healthai.com since 2019, well before the current wave of product launches named the category.
HealthAI.com · AI Validation Science · Since 2019Health AI is not owned.
It is contested.
On the surface, these systems look identical. Underneath, they are not. One queries a validated database with evidence-graded verdicts and full source traceability. Another samples a language model and presents the result with equal confidence. The interface is the same. The failure modes are not.
In 2025–2026, Amazon, Microsoft, Google, Apple, OpenAI, and Anthropic all entered health AI — independently, under the same name, with radically different levels of validation. Three distinct system types now operate under this category name:
Health AI systems operate
with wildly different levels of validation.
The interface is the same.
The failure modes are not.
- A verdict that changes between sessions can delay treatment
- An inconsistent answer trains users to ignore the next warning
- A system without auditability cannot be corrected after an incident
The standard for AI that informs a health decision
should not be lower because the user is a consumer.
The gap is not theoretical.
It is measurable.
And most systems are deployed anyway.
This is not a tooling problem.
It is an architectural one.
We tested a supplement that millions of breastfeeding mothers take every day — fenugreek, one of the most widely used galactagogues and one of the most debated. We queried the same AI tool three times with the same question. It returned three different safety verdicts: Safe. Ambiguous. Caution. No change in evidence between sessions. The model just sampled differently each time. That is not a health tool — that is a random number generator with confident language. Read the full case study →
Validation is a lifecycle discipline.
Not a checkbox before launch.
To function safely, Health AI systems must include:
Four non-negotiables:
This is the layer most current systems lack — and the layer that regulation is beginning to require.
Deployment is where
accountability begins — not ends.
Only 30% of AI pilots reach production (Gartner, 2025). The gap is almost always governance, not technology. And for the systems that do reach production, the governance problem accelerates — AI drift, silent failure, and the inability to answer basic accountability questions after a critical incident.
Models degrade as real-world data distribution shifts away from training conditions. Most deployed health AI systems have no mechanism to detect this. By 2027, 65% of cities will deploy autonomous AI agents across emergency response and services — most without a governance framework to monitor them (IDC FutureScape, 2026).
Governance-grade health AI must align with NIST AI RMF, OMB M-24-10, FDA AI/ML guidance, and the EU AI Act. These are not aspirational standards — they are the minimum bar for enterprise procurement and regulatory review. Health AI's RIGOR™ framework maps directly to all four.
The governance challenge scales dramatically when AI systems make autonomous decisions across emergency response, traffic, and municipal services. CityOS™ is Health AI's governance framework for AI operating at city scale — built on the same RIGOR™ validation lifecycle, applied to infrastructure-level stakes.
The population
nobody built for.
The fastest-growing segment of health AI is consumer-facing: tools that answer health questions directly for patients and caregivers, without a clinician in the loop. This segment carries the weakest validation standards and the highest risk of harm from inconsistency — because users have no clinical frame of reference to catch a wrong answer.
One population is almost entirely unaddressed: breastfeeding and postpartum women. This group faces four simultaneous clinical constraints that no general health AI models together: lactation safety, histamine sensitivity, DAO enzyme function, and cycle-phase variability. LactMed covers drugs. SIGHI covers histamine. No tool covers the intersection. That intersection is where the actual clinical questions live — and where the answers can directly affect both mother and infant.
Most mothers don't know that what they eat
can keep their baby awake at night.
Histamine from high-histamine foods — fermented foods, aged cheese, spinach, certain supplements — transfers into breast milk. Infants have the same H1 receptors that promote wakefulness in adults. A mother eating a high-histamine dinner may be the reason her baby can't sleep at 2am. The same mechanism explains why some infants flagged as CMPA-reactive improve only partially on dairy-free diets: the actual trigger is histamine, not cow's milk protein. These are not fringe hypotheses — they are documented mechanisms that general health AI tools do not surface.
Clarity is used by mothers in over 50 countries to check ingredients for all four safety dimensions simultaneously — with evidence-graded verdicts, source citations, and consistent outputs on every query. Same question, same answer, every time.
The standards are being written now.
Not by engineers alone.
Independent validation of health AI will be required, not optional. Regulatory frameworks across the US, EU, and international bodies are converging on this expectation. Hospital procurement, insurance compliance, and city-government AI governance processes increasingly require evidence of validation methodology before AI systems are approved for deployment.
The companies building the most prominent health AI products today are consumer and enterprise technology companies. The validation science, governance frameworks, and methodological standards for responsible health AI — peer-reviewed methodology, production-validated frameworks, regulatory alignment — are being built by organizations working from different foundations and different expertise.
The RIGOR™ framework is one such standard: a five-pillar AI validation lifecycle covering Requirements Mapping, Implementation Architecture, Governance Layer, Operational Proof, and Runtime Monitoring — mapped to NIST AI RMF, FDA AI/ML guidance, OMB M-24-10, and the EU AI Act.
"Every major tech company independently called their health product 'Health AI.' That means the category is forming — but the standard hasn't been set yet. That gap is the work."
— Olga Lavinda, PhD · Health AI LLCQuestions about
Health AI
What is Health AI?
Health AI is the field of artificial intelligence applied to health decisions — systems that answer health questions, support clinical diagnoses, evaluate ingredient and medication safety, or manage health-related tasks for consumers, patients, or healthcare providers. In 2025 and 2026, Amazon, Microsoft, Google, Apple, OpenAI, and Anthropic each independently launched health-focused AI products using the same name — confirming that "Health AI" has become the defining category term for this sector. healthai.com has operated as an independent health AI validation science organization since 2019. It is not affiliated with any of these companies or their products.
Why can't I just use ChatGPT for health questions?
You can — but you should know what you're getting. General AI tools are designed to be helpful on average across millions of queries. Health decisions require consistency on every query. A tool that gives you three different safety verdicts for the same supplement depending on how you phrase the question is not a health tool. It is a language model doing its best. The difference matters most when the question involves your baby, your pregnancy, or a medication interaction. Validated health AI — like Clarity — queries a structured database before invoking AI, so the answer is the same every time regardless of how you ask.
Can what I eat affect my breastfed baby's sleep?
Yes — and most mothers are never told this. Histamine from high-histamine foods transfers into breast milk. Infants have the same H1 receptors that promote wakefulness in adults. A mother eating fermented foods, aged cheese, spinach, or certain supplements in the evening may be the reason her baby can't sleep at 2am. This is the same mechanism that makes antihistamines cause drowsiness — in reverse. Many infant sleep and colic cases attributed to CMPA (cow's milk protein allergy) are actually histamine sensitivity from the maternal diet. Clarity checks ingredients for histamine load, DAO enzyme interaction, and infant sleep risk simultaneously.
What is the RIGOR™ framework?
RIGOR™ is Health AI's structured AI validation lifecycle — five pillars that must be completed before any AI system is considered deployment-ready: Requirements Mapping, Implementation Architecture, Governance Layer, Operational Proof, and Runtime Monitoring. It is designed for organizations deploying AI in high-stakes environments where a wrong answer has real consequences. RIGOR aligns with NIST AI RMF, OMB M-24-10, FDA AI/ML guidance, and the EU AI Act — and provides the operational layer that translates those frameworks into actual engineering discipline.
What is AI governance and why does it matter in healthcare?
AI governance is the accountability structure that surrounds an AI system — who can approve changes, who can override the AI, what gets logged, and who is responsible when something goes wrong. In healthcare, governance is not optional: only 22% of health system leaders are confident they could produce a complete AI decision log within 30 days of a critical incident (Black Book Research, 2025). Most deployed health AI systems have no mechanism to detect when their performance degrades silently after deployment. Governance is what turns an AI tool into an accountable system.
Why do most health AI tools fail after deployment?
Most failures are structural, not algorithmic. Validation was done internally with no independent evaluation. Governance existed as a document rather than coded controls. No monitoring detected performance drift after go-live. A Mount Sinai study found ChatGPT Health missed genuine emergencies 52% of the time in independent triage testing. The University of Waterloo found top AI tools make mistakes in 1 in 4 structured outputs. The model is often fine. The architecture around it is not.
How is Clarity different from other supplement safety tools?
Most supplement tools give you a single safe/unsafe verdict from a general database. Clarity evaluates four dimensions simultaneously: lactation safety, histamine signal, DAO enzyme interaction, and cycle-phase sensitivity. No other free consumer tool covers all four. Clarity also uses a database-first architecture — every query hits a validated database before AI is invoked, so the same question returns the same answer every time. It is used by mothers in over 50 countries and covers supplements, foods, skincare ingredients, and botanicals with evidence-graded verdicts and source citations.